Vaniqa has been discontinued in the United States. The brand-name manufacturer, Allergan (now part of AbbVie), stopped producing Vaniqa in the first quarter of 2023, and no FDA-approved generic version exists. If you had a prescription or were hoping to get one, the cream is no longer stocked at U.S. pharmacies.
What Happened to Vaniqa
Vaniqa was the only FDA-approved topical cream for reducing unwanted facial hair in women. It contained eflornithine hydrochloride at 13.9% concentration and was applied twice daily. Allergan discontinued it in early 2023 without a publicly stated reason, and the American Society of Health-System Pharmacists lists zero presentations currently available in the U.S.
No other pharmaceutical company has stepped in with an FDA-approved generic. Some non-FDA-reviewed topical eflornithine products may appear online, but these have not been evaluated for safety or effectiveness by U.S. regulators.
Availability Outside the U.S.
Vaniqa is still available in the United Kingdom through licensed online pharmacies. UK-based services like Dr Fox sell Vaniqa cream (in 60-gram tubes) on prescription after a medical questionnaire, with prices starting around £67 for a single tube that lasts roughly two months. Ordering prescription medication from overseas pharmacies comes with its own legal and safety considerations depending on where you live, so this isn’t a straightforward workaround for U.S. residents.
How Vaniqa Worked
Eflornithine slows facial hair growth by blocking an enzyme that hair follicles need to produce new hair. It doesn’t remove existing hair. Instead, it makes regrowth finer, lighter, and slower over time. In clinical trials, visible improvement typically started within 4 to 8 weeks. By 24 weeks, about 32% of patients using Vaniqa showed marked improvement, compared to just 8% using a placebo cream.
When combined with light-based hair removal treatments, the results were significantly better. One randomized trial found that pairing eflornithine with intense pulsed light led to 90% reduction in terminal hair at 24 weeks, compared to 59% with light therapy alone. That combination approach is no longer an option for most U.S. patients without access to the cream.
One important detail: hair growth returned to its previous rate within about 8 weeks of stopping the cream. Vaniqa was always a maintenance treatment, not a cure.
Side Effects Were Generally Mild
For those who used Vaniqa, the most common side effects were stinging, burning, or tingling at the application site, along with redness, rash, or acne. Some people developed swollen patches of skin around ingrown hairs. Severe skin irritation was uncommon but warranted stopping the cream. The medication was applied topically and had minimal systemic absorption at normal doses.
Alternatives for Facial Hair Reduction
With Vaniqa off the U.S. market, the remaining options for managing unwanted facial hair fall into two categories: medications that address the hormonal cause and physical hair removal methods.
Oral Medications
Spironolactone is the most commonly prescribed oral medication for hirsutism. It works by blocking the effects of androgens, the hormones that drive coarse hair growth in areas like the face, chest, and abdomen. Results are modest and take at least six months to appear. Side effects can include irregular periods, and the drug causes birth defects, so reliable contraception is essential while taking it. Other anti-androgen medications and hormonal birth control pills are sometimes used as well, particularly when excess hair growth is linked to conditions like polycystic ovary syndrome.
Hair Removal Procedures
Laser hair removal and electrolysis remain the most effective long-term options for reducing facial hair. Laser works best on dark hair against lighter skin, though newer devices have expanded the range of skin tones that respond well. Multiple sessions are needed, typically spaced several weeks apart. Electrolysis destroys individual hair follicles with an electric current and works on all hair and skin types but is slower since it treats one follicle at a time. Both methods can produce lasting results, though occasional maintenance sessions are common.
Previously, many dermatologists recommended using Vaniqa alongside laser or electrolysis to improve outcomes between sessions. Without the cream, these procedures still work but may require more patience during the early treatment phase when regrowth is still active.